EU-funded scientists have been seeking to understand the behaviour of immune cells important for combating diseases such as cancer by using chemical probes that ‘switch on’ when the cells become active.
Scientists working on the EU-funded ENDOIMAGE project have developed a new type of chemical probe that can provide information on how the body’s immune cells react to a range of diseases. The technology, which can be used for imaging key molecular events in cancer, is based on chemical compounds which emit fluorescent light called fluorophores.
Further details: Understanding the body’s immune responses with the help of fluorescent chemical probes